Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  COVID-19

  Free Subscription


Articles published in Zhonghua Jie He He Hu Xi Za Zhi

Retrieve available abstracts of 63 articles:
HTML format



Single Articles


    November 2020
  1. NIE NF, He Y
    [Potential therapeutic drugs for novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:970-974.
    PubMed     Abstract available


    October 2020
  2. WANG X, Hu ZW, Hu Y, Cheng Y, et al
    [Comparison of severity classification of Chinese protocol, pneumonia severity index and CURB-65 in risk stratification and prognostic assessment of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:834-838.
    PubMed     Abstract available



  3. [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:827-833.
    PubMed     Abstract available


    September 2020

  4. [Recommendation of respiratory rehabilitation for PICS in critically ill patients with COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:737-743.
    PubMed     Abstract available


  5. ZHAN X, Liu B, Tong ZH
    [Postinflammatroy pulmonary fibrosis of COVID-19: the current status and perspective].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:728-732.
    PubMed     Abstract available


  6. XIA JG, Li M, Zhan QY
    [Intervention timing of invasive mechanical ventilation and extracorporeal membrane oxygenation in the treatment of severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:725-728.
    PubMed    


  7. PAN PH, Song C, Lu RL
    [The timing of continuous renal replacement therapy in severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:721-724.
    PubMed    


  8. XIE LX, Xie SL
    [Immune imbalance and immunoregulatory treatment of COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:717-721.
    PubMed    


    August 2020
  9. ZHU Q, Zhang W, Wang Q, Liu JH, et al
    [Clinical characteristics and outcome of 64 patients with severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:659-664.
    PubMed     Abstract available


  10. ZENG YL, Zhang C, Gao F, Ma L, et al
    [Analysis of clinical characteristics of 49 cases of COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:654-658.
    PubMed     Abstract available


  11. QIN W, Hu BZ, Zhang Z, Chen S, et al
    [Clinical characteristics and death risk factors of severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:648-653.
    PubMed     Abstract available


    June 2020
  12. LU XF, Gong W, Wang L, Li L, et al
    [Clinical features and high resolution CT imaging evolution of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:509-515.
    PubMed     Abstract available



  13. [Guide for the prevention and treatment of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:473-489.
    PubMed     Abstract available


    May 2020
  14. ZHANG SX, Li J, Zhou P, Na JR, et al
    [The analysis of clinical characteristics of 34 novel coronavirus pneumonia cases in Ningxia Hui autonomous region].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:431-436.
    PubMed     Abstract available



  15. [Diagnosis and Treatment Protocol for COVID-19 from Military Medical Team Supporting Wuhan (Trial Version 2)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:414-420.
    PubMed     Abstract available


  16. ZHAO Q, He Y
    [Application of convalescent plasma therapy on novel coronavirus infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:409-413.
    PubMed     Abstract available


    April 2020

  17. [Expert consensus on sleep study and non-invasive positive airway pressure therapy during the epidemic of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E043.
    PubMed     Abstract available


  18. SUN C, Zhang XB, Dai Y, Xu XZ, et al
    [Clinical analysis of 150 cases of 2019 novel coronavirus infection in Nanyang City, Henan Province].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E042.
    PubMed     Abstract available


  19. LIU YJ, Yang YL, Xu Y
    [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:339-344.
    PubMed     Abstract available


  20. TAN FR, Qiu YL, Xu Z
    [Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:337-339.
    PubMed     Abstract available



  21. [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:308-314.
    PubMed     Abstract available



  22. [Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:288-296.
    PubMed     Abstract available


  23. LI XY, Du B, Wang YS, Kang HYJ, et al
    [The keypoints in treatment of the critical coronavirus disease 2019 patient(2)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:277-281.
    PubMed     Abstract available


  24. SHI Y
    [What are the highlights of "Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team"].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:315-320.
    PubMed     Abstract available


  25. QIU HB, Li XY, Du B, Kang HYJ, et al
    [The keypoints in treatment of the critical coronavirus disease 2019 patient(1)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:273-277.
    PubMed     Abstract available


  26. ZHANG T, Sun LX, Feng RE
    [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E040.
    PubMed     Abstract available


    March 2020
  27. REN YH, Wang SY, Liu M, Guo YM, et al
    [When COVID-19 encounters interstitial lung disease: challenges and management].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E039.
    PubMed     Abstract available


  28. LI HC, Ma J, Zhang H, Cheng Y, et al
    [Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E038.
    PubMed     Abstract available


  29. SUN ML, Yang JM, Sun YP, Su GH, et al
    [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:219-222.
    PubMed     Abstract available


  30. ZHANG MQ, Wang XH, Chen YL, Zhao KL, et al
    [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:215-218.
    PubMed     Abstract available


  31. CHEN L, Liu HG, Liu W, Liu J, et al
    [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:203-208.
    PubMed     Abstract available



  32. [Expert consensus for bronchoscopy during the epidemic of 2019 novel coronavirus infection (Trial version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:199-202.
    PubMed     Abstract available



  33. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:185-188.
    PubMed     Abstract available


  34. ZHAO JP, Hu Y, Du RH, Chen ZS, et al
    [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:183-184.
    PubMed    


  35. YANG F, Liu N, Hu JY, Wu LL, et al
    [Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:180-182.
    PubMed     Abstract available


  36. YUAN X, Mu JS, Mo GX, Hu XS, et al
    [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:177-180.
    PubMed     Abstract available


  37. DU B, Qiu HB, Zhan X, Wang YS, et al
    [Pharmacotherapeutics for the new coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:173-176.
    PubMed     Abstract available


  38. LI H, Wang YM, Xu JY, Cao B, et al
    [Potential antiviral therapeutics for 2019 Novel Coronavirus].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:170-172.
    PubMed     Abstract available


  39. ZHOU L, Liu HG
    [Early detection and disease assessment of patients with novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:167-170.
    PubMed     Abstract available


  40. GAO ZC
    [Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:163-166.
    PubMed     Abstract available



  41. [Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E034.
    PubMed     Abstract available


  42. TIAN XL, Peng M, Wang HP, Cai BQ, et al
    [The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E035.
    PubMed     Abstract available


  43. CAI SJ, Wu LL, Chen DF, Li YX, et al
    [Analysis of bronchoscope-guided tracheal intubation in 12 cases with COVID-19 under the personal protective equipment with positive pressure protective hood].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E033.
    PubMed     Abstract available



  44. [Expert consensus on Pulmonary Function Testing during the epidemic of Corona Virus Disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E032.
    PubMed     Abstract available



  45. [Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E031.
    PubMed     Abstract available


  46. WU J, Feng CL, Xian XY, Qiang J, et al
    [Novel coronavirus pneumonia (COVID-19) CT distribution and sign features].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E030.
    PubMed     Abstract available



  47. [Recommendations for respiratory rehabilitation of COVID-19 in adult].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E029.
    PubMed     Abstract available


  48. ZHOU L, Liu K, Liu HG
    [Cause analysis and treatment strategies of "recurrence" with novel coronavirus pneumonia (covid-19) patients after discharge from hospital].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E028.
    PubMed     Abstract available


  49. CHENG JL, Huang C, Zhang GJ, Liu DW, et al
    [Epidemiological characteristics of novel coronavirus pneumonia in Henan].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E027.
    PubMed     Abstract available


    February 2020
  50. LI XY, Du B, Wang YS, Kang HYJ, et al
    [The keypoints in treatment of the critical coronavirus disease 2019 patient].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E026.
    PubMed     Abstract available


  51. LI YY, Wang WN, Lei Y, Zhang B, et al
    [Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E023.
    PubMed     Abstract available



  52. [Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;17:E020.
    PubMed     Abstract available



  53. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E019.
    PubMed     Abstract available


  54. SUN ML, Yang JM, Sun YP, Su GH, et al
    [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E014.
    PubMed     Abstract available


  55. DU B, Qiu HB, Zhan X, Wang YS, et al
    [Pharmacotherapeutics for the New Coronavirus Pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E012.
    PubMed     Abstract available


  56. YUAN X, Mu JS, Mo GX, Hu XS, et al
    [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E010.
    PubMed     Abstract available


  57. ZHAO JP, Hu Y, Du RH, Chen ZS, et al
    [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E007.
    PubMed    



  58. [Expert consensus for bronchoscopy during the epidemic of 2019 Novel Coronavirus infection (Trial version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E006.
    PubMed     Abstract available


  59. CHEN L, Liu HG, Liu W, Liu J, et al
    [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E005.
    PubMed     Abstract available


  60. YANG F, Liu N, Wu JY, Hu LL, et al
    [Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E004.
    PubMed     Abstract available


  61. ZHOU L, Liu HG
    [Early detection and disease assessment of patients with novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E003.
    PubMed     Abstract available


  62. LI H, Wang YM, Xu JY, Cao B, et al
    [Potential antiviral therapeutics for 2019 Novel Coronavirus].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E002.
    PubMed     Abstract available


  63. GAO ZC
    [Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E001.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: